Clinical Trials Logo

Filter by:
NCT ID: NCT03557320 Completed - Clinical trials for Spontaneous Pneumothorax

Environmental Factor and Onset of Spontaneous Pneumothorax

EXPPO
Start date: May 31, 2013
Phase:
Study type: Observational

The study aims to evaluate the association between spontaneous pneumothorax onset and weather parameters.

NCT ID: NCT03557307 Completed - Asthma Clinical Trials

Study to Evaluate Efficacy and Safety of Benralizumab in Reducing Oral Corticosteroid Use in Adult Patients With Severe Asthma

PONENTE
Start date: August 1, 2018
Phase: Phase 3
Study type: Interventional

This is a study designed to evaluate efficacy and safety of Benralizumab in reducing the Oral Corticosteroid (OCS) use in adult patients with severe asthma who are receiving OCS with or without additional asthma controller medications.

NCT ID: NCT03556956 Completed - Clinical trials for Colorectal Cancer Metastatic

Masitinib in Combination With FOLFIRI in Third or Fourth Line of Treatment of Patients With Metastatic Colorectal Cancer

Start date: July 2015
Phase: Phase 2/Phase 3
Study type: Interventional

A prospective, multicentre, open-label, randomized, phase 2-3 study to compare the efficacy and safety of masitinib in combination with FOLFIRI (irinotecan, 5-fluorouracil and folinic acid) versus Best Supportive Care, in third or fourth line treatment of patients with metastatic colorectal cancer

NCT ID: NCT03556813 Completed - Breast Cancer Clinical Trials

Artificial Intelligence vs Physicians for Breast Cancer Patients' Information

Start date: November 1, 2018
Phase:
Study type: Observational

Chatbots (contraction of "chat" and "robot") are a computer software program that use statistical learning and aim to simulate a conversation by text or voice message. The use of these chatbots was evaluated as part of the increase in therapeutic adherence and information on well-being and mental health. In clinical studies, chatbots are useful in gathering information through questionnaires directly submitted during conversations or through keyword analyzes. There is no longer any delay between the moment the patient notices a side effect, for example, and the moment when the patient announces it during a consultation. The responses given by the chatbot do not constitute medical advice and only provide information on the treatments envisaged or in progress in the context of the management of breast cancer. The main objective of the study is to show that the chatbot Vik's answers to the common questions asked by breast cancer patients about their therapeutic management are at least as satisfactory as answers given by a committee of multidisciplinary doctors

NCT ID: NCT03556696 Completed - Clinical trials for Surgical Procedure, Unspecified

Automatic Remifentanil Administration Guided by ANI During Propofol Anesthesia

ANI-LOOP
Start date: June 27, 2018
Phase: N/A
Study type: Interventional

Prospective Randomized Monocentric Clinical Trial during propofol anesthesia. The aim of the study is to test whether the use of a medical device designed to automatically administer remifentanil during surgery based on expert rules and continuous reading of heart rate, blood pressure and the Analgesia Nociception Index results in lower overall remifentanil administration versus standard practice.

NCT ID: NCT03556592 Completed - Atopic Dermatitis Clinical Trials

Drug-drug Interaction Trial With Tralokinumab in Moderate to Severe Atopic Dermatitis - ECZTRA 4

Start date: August 13, 2018
Phase: Phase 1
Study type: Interventional

The purpose of this trial is to investigate if tralokinumab changes the metabolism of selected CYP substrates in adults with moderate-to-severe AD after: - 14 weeks of treatment with tralokinumab - a single dose of tralokinumab

NCT ID: NCT03555929 Completed - Wrist Fracture Clinical Trials

Impact on Sensitivity and Motor Block Duration of an Intravenous Dexamethasone an Axillary Block With Mepivacaine.

DEXA-rescue
Start date: April 4, 2018
Phase: Phase 3
Study type: Interventional

Intravenous dexamethasone is used to increase the duration of analgesia of interscalene bloc for shoulder surgery: it extends from 11h to 23h the sensitivity block in shoulder area. However, the time of dexamethasone intravenous injection has not been studied. In all studies, dexamethasone was injected right after the achievement of loco regional anesthesia. The main objective is to demonstrate that intravenous injection of dexamethasone delayed at 90 minutes in patients who received an axillary block with mepivacaine prolongs the duration of the motor block by 40 minutes.

NCT ID: NCT03555916 Completed - Clinical trials for Trigeminal Neuropathy, Traumatic

Botulinum Toxin Injections for Oral Neuropathic Pain

TRIGTOX
Start date: April 4, 2019
Phase: Phase 3
Study type: Interventional

Peripheral painful traumatic trigeminal neuropathy (PPTTN) are poorly relieved by existing treatments which in addition induce many adverse effects. BTX, which blocks the exocytosis of neurotransmitters, can be captured by axonal retrograde transport in primary nociceptive neurons. Injected in the painful area, it might therefore inhibit the release of algogenic neurotransmitters, at both the peripheral and central levels and thus reduce pain. One study reported such an effect in neuropathic spinal pain. A recent study reported an analgesic effect in trigeminal neuralgia.

NCT ID: NCT03555864 Completed - Obesity, Morbid Clinical Trials

Intravenous Access Using Infrared Laser

AccuV
Start date: November 6, 2017
Phase:
Study type: Observational

Peripheral venous access is a prerequisite for anesthesiological for surgical patients.It is often difficult to establish and potentially painful in obese patients (Body mass Index > 35). AV300 uses near infrared laser light to improve visibility of peripheral veins and could help cannulating them. The aim of this study was to examine if use of Accuvein(®) AV300 vein viewer could facilitate venous cannulation in obese patients (surgical and obstetric).

NCT ID: NCT03555812 Completed - Clinical trials for Arthroplasty, Replacement, Hip

Pelvic Inclination Measurement by Navigated Ultrasound

MIPEN
Start date: July 18, 2018
Phase: N/A
Study type: Interventional

Prospective, multicenter, non-randomized study. Primary endpoint : to confirm the proper functioning of the device in vivo by analyzing intra and interobserver reproducibility of repeated measurements on healthy controls. Secondary endpoint : to describe the values of pelvic inclination while standing, sitting and lying in patients with severe hip osteoarthritis before and after total hip arthroplasty After signing the inform consent form: For the first endpoint (, 3 healthy volunteers of different morphotypes will have one consultation comprising : - a medical examination - 10 measurements of pelvic inclination in sitting position, 10 measurements of pelvic inclination in supine position and 10 measurements of pelvic inclination in standing position, each realized per three different operators. These measurements will be carried out with navigated ultrasound. For the secondary endpoint, 30 patients awaiting for a hip replacement surgical intervention will realized one consultation the day before the intervention, and one consultation at 2 months after surgery, each comprising : - a medical examination - 3 measurements of pelvic inclination (1 standing, 1 sitting and 1 supine). These measurements will be carried out with navigated ultrasound.